Arginase from normal human mixed saliva was characterized. The enzyme was completely activated after a preincubation of 20min at 55 °C and a Mn 2+ final concentration of 5 mmol/1. The pH Optimum was 9.6-9.8, and the K m for L-arginine was 4.2 ± 0.7 mmol/1. In normal saliva only one form was found, which was chromatographically identical with the cationic form of arginase in liver and blood cells. Salivary arginase was completely precipitated by rabbit aiitiserüm against human liver arginase.
Introduction
erythrocytes (2-4) and leukocytes (5) . In this paper Argininaemia is an inborn metabolic disorder of the we report deficient arginase activity in the saliva of urea cycle dtie to arginase (L-arginine-homozygous patients, together with our fmdings on amidinohydrolase, EC 3.5.3.1) deficiency. The en-the properties of arginase from normal human saliva. zyme deficiency has been demonsträted in liver (1) , Kinetic, Chromatographie and immunological ' Presented in part at the 3rd International Symposium on similarities of salivary, hepatic and blood cell Inborn Errors in Humans, Munich 1984. arginases suggest that they are genetically identical.
Materials and Methods

Sumpling and preparation ofsaliva
Saliva was sampled from 60 healthy adults, aged 18 -65 years, 8 healthy children, aged l to 4 years, and from three siblings with argininaemia (6) , their heterozygous parents and healthy sister. Two individual samples at intervals of an hour were obtained from each patient. Specimens of mixed saliva were taken during unstimulated secretion foliowing prior rinsing of the oral cavity. They were centrifuged at 1200# for 5 min and the supernatant used for enzyme determinations.
Before the arginase assay, salivary mucus was dispersed by sonication at 0 °C (2 χ 20s, 40 W, Sonifier B I2 , Branson Sonic Power Company, USA) or emulsified by homogenization in a Teflonglass Potter type homogenizer for l min at 2000 min" 1 .
For Chromatographie and immunological procedures, saliva was homogenized with 2-mercaptoethanol in a final concentration of 0.2 mol/1, and incubated at 0 °C for 2 hours in Order to lower mucus viscosity (7) . Any precipitate was then removed by centrifugation and the supernatant was used for further investigation.
Arginase assay
Arginase activity was measured by the amount of ornithine liberated from L-arginine s Substrate. Ornithine was determined by the method of Chinard (8) .
For the arginase assay, saliva from healthy subjects was diluted 5-fold. The reaction mixture (0.5 ml) contained 0.5 μπιοί of MnCl 2 , 10 μπιοί of arginine and 30 μηιοί of carbonate buffer, all adjusted to pH 9.8, and 0.05 ml of enzyme preparation. After incubation at 37 °C for 15 min, the reaction was stopped with 1.5ml of concentrated acetic acid, then 0.5ml of ninhydrin solution was added (2.5g of ninhydrin in a mixture of 40ml of 6 mol/1 H 3 PO 4 and 60 ml of glacial acetic acid). After heating in-a boiling water bath for l hour the mixture was cooled and the absorbance was read at 515 nm against a reagent blank. A zero time blank was performed for each individual specimen of saliva.
To measure fully Mn 2+ -activated arginase, the mixtures containing 0.05 ml of enzyme preparation and 0.05 ml (0.5 μπιοί) of MnCl 2 were preincubated at 55 °C for 20 min. After cooling, arginine and carbonate buffer were added, and the procedure was performed s described above. Arginase in erythrocytes was determined s described previously (9) .
Arginase activity was expressed in units per mg of protein. One unit of arginase is defmed s the amount of enzyme that produces l μπιοί of ornithine per minute at 37 °C.
Protein was measured according to Lowry et al. (10) with cristalline bovine serum albumin s a Standard.
Ιοη-exchange chromatography
For chromatography on DEAE-or CM-cellulose, saliva was homogenized and incubated with 2-mercaptoethanol and then dialysed overnight against 5 mmol/l MnCl 2 in 5 mmol/1 Tris-HC1 buffer, pH 8.3 or 7.5 respectively. Any precipitate was removed by centrifugation and the supernatant was applied to the cellulose column (l χ 18cm) equilibrated with 5 mmol/1 Tris-HCl buffer, pH 8.3 (DEAE-cellulose) or pH 7.5 (CMcellulose). The columns were eluted with 30 ml of the equilibration buffer followed by a linear KC1 concentration gradient (up to 0.3 mol/1) in the same buffer. Fractions of 5 ml were collected.
Immunological procedures
We used a rabbit antiserum against homogenous arginase from human liver, which was the A, form of arginase according to Porembska's terminology (l 1). The antiserum was prepared and tested s recently described (12) .
Titration of arginase with antibodies was performed in mixtures containing the enzyme preparation (0.1 -0.3 unit), MnCl 2 in a final concentration of 5 mmol/1, and appropriate dilution of the antiserum in increasing amounts (0-50 μΐ). The samples were adjusted to a final volume of l ml with 5 mmol/1 TrisHCl buffer, pH 7.5. Control samples, instead of antiserum, contained normal rabbit serum in appropriate amounts. The mixtures were incubated at 37 °C for 3 f O min and then at 4 °C for 18 hours to aggregate the enzyme-antibody complexes. They were then removed by centrifugation at 25000g for 30 min, and the residual arginase activity determined in the supernatant. The residual fraction of arginase activity remaining in the supernatant was expressed in relation to the units of arginase added, which were taken s 1.00. The amounts of the antiserum added were expressed per l unit of arginase.
Results
Bacterial contamination
The presence of the physiological bacterial flora has no infl ence on arginase activity in saliva. Specimens of saliva after centrifugation and incubation with 2-mercaptoethanol at 0 °C for 2 hours were filtered through the Millipor bacteriological filier type HA 0.45 μτη. No difference were found in arginase activity before and after filtration.
Enzyme characteristics
Manganese dependence
Incubation at 55 °C for 20 min with a Mn 2+ -concentration of 5 mmol/1 fully activates salivary arginase ( fig. la/b) . High concentrations inhibit the enzyme. In the presence .of the same Mn 2+ concentration, the average activity after preinc bation is 3 times higher than witho t preinc bation (tab. 1).
pH Optimum
The pH Optimum of the activated enzyme in carbonate buffer was 9.6-9.8 ( fig. 2 ).
Michaelis constant
The K m of the activated salivary arginase for arginine at pH 9.8 was 4.2 ± 0.7 mmol/1 ( fig. 3 ).
Stability on storage
Salivary arginase was more stable on storage at 0 °C than at -10°C. At 0°C no detectable loss of the enzyme activity was observed for at'least two days. After one week the enzyme still retained 80% of its initial activity. At -10 °C the enzyme was extremely o labile, losing a fraction of about 0.50 of its initial activity in one day (fig. 4) . 
Chromatographie properties
Ion exchange chromatography on DEAE-and CMcellulose revealed a single cationic form of arginase in human normal saliva ( fig. 5a /b). The enzyme was not absorbed on DEAE cellulose at pH 8.3 and was eluted from the column with the equilibrating buffer.
On CM-cellulose a single arginase peak was eluted with a KC1 concentration gradient.
Immunological properties
Antiserum titrations and immunoprecipitations of salivary arginase were carried out with rabbit antiserum against human liver arginase. The antiserum also cross-reacted with arginase in the saliva of argininaemia heterozygotes and in normal human erythrocytes ( fig. 6 ).
Arginase catalytic activity in saliva
Arginase activity in saliva of normal subjects
Arginase activity in the saliva of 60 normal adults increased after activation with Mn 2+ and amounted to 0.17 ± 0.11 U/mg protein. The within assay CV was 3.8% for a mean activity of 0.09 Ü/mg protein.
We found no significant differences in the activities of salivary arginase of normal adults and children. In both age groups the ränge of the enzyme activity was wide (tab. 1).
To evaluate variations of enzyme activity in the saliva of the same subjects, arginase was assayed in speci* mens taken repeatedly during several days from the same person. We found differences up to 7 the enzyme activity in various samples from the same donor ( fig. 7) . 
Activity of salivary arginase in argininaemia
The activity of arginase in the saliva of argininaemia homozygotes was not detected under the assay conditions used for normal saliva. Arginase activity in the saliva of the heterozygous parents and the unaffected daughter was within the r nge of the control group (tab. 2). 
Discussion
Arginase catalyzes the last Step of the urea cycle. In humans it is found mainly in the liver; lower catalytic activities have been observed in erythrocytes, leukocytes, platelets, kidney, skeleton and heart muscle, brain, intestines, pancreas, hing, epidermis, placenta, testes, plasma and fibroblasts (9) . The metabolic function of extrahepatic arginase is still unclear.
Arginase in saliva originales from the salivary glands.
In man it has been demonstrated in the parotid gland (13) . Its origin from serum can be excluded, because its activity in serum (14) is up to 400 times lower than in saliva (15) . We found a pH optimum of 9.6 and a maximal manganese activation at 5 mmol/1, compared to pH 9.3 and a Mn 2+ -concentration of 2 mmol/1 for the purified liver enzyme (16).
The AT m of 4.2 ± 0.7 mmol/1 is of similar magnitude to values reported in the literature for the liver enzyme, i.e. 2.5, 5.3 and 7.4 mmol/1 (16, 17, 18) , respectively. Our findings are in agreement with those of Gopalakrishna & Nagarajan who reported a Mn 2+ activation at 2 mmol/1, a K m of 5 mmol/1, a pH optimum of 9.7 -10.0 s well s storage instability (15) . Chromatography on DEAE-and CM-cellulose showed one peak, corresponding to the isoenzyme AI according to Porembska, which is the major component of human liver (0.85) and red blood cell (0.80) arginase (11).
Antibodies against human liver arginase A! cross reacted with the salivary enzyme. On the bases of these findings, we postulate that salivary arginase corresponds to the liver type A r isoenzyme. This isoenzyme has been demonstrated by Porembska in the parotid gland tissue (13) and contributes chiefly to the arginase activity of mixed saliva.
Mixed saliva can easily be collected during unstimulated secretion. It has increasingly been used instead of separate collection of saliva for clinical chemical analysis of hormones, drugs and enzymes. Arginase activity in mixed saliva has recently been used s a parameter to evaluate the nutritional Status ofchildren (19) .
Mixed saliva was also used in our patients because collecting samples from separate glands was impossible in the three mentally retarded children with argininaemia. However, in this case, we have ruled out the possibility of interference from bacterial arginase. Arginase activity, even with complete activation, is very low in mixed saliva. This may be related to the low activity of arginase observed in the parotid gland (13) , which was 400 times lower than in liver tissue and about 6 times lower than in red blood cells.
There was a large overlap between argininaemic heterozygotes and normal individuals. The explanation for this remains uncertain. Since the enzyme activity has been referred to the protein concentration, changes in protein content in relation to the salivary flow rate may influence the results. These changes, however, are small under the conditions applied here, and they would be of consequence only for a prolonged and intensive Stimulation of the salivary glands (20) . Whether arginase secretion is flow-dependent was not examined. In view of the recent observations with salivary amylase this is rather improbable at low basic secretion rates (21) . The overlap between normal individuals and heterozygotes may therefore be attributed to biological variations.
No activity was demonstrated in the saliva of the argininaemia patients. Saliva can therefore be used for rapid enzyme determination. In our opinion the diagnosis of argininaemia, however, raust be confirmed by enzymatic determination in red cell preparations and, if possible, in liver tissue.
The kinetic, Chromatographie and immunological similarities of liver, red blood cell and salivary arginase suggest their genetic identity. Its deficiency in argininaemia provides evidence that although this protein originates from clifferent tissues, it is under the control of the same gene locus.
